These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7589337)

  • 1. Presenting features, natural history, and prognostic factors in localized non-Hodgkin's lymphomas: analysis of 117 cases from a single institution.
    Esteve J; López-Guillermo A; Martínez-Francés A; Bosch F; Terol MJ; Campo E; Montserrat E; Rozman C
    Eur J Haematol; 1995 Oct; 55(4):217-22. PubMed ID: 7589337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
    Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.
    López-Guillermo A; Montserrat E; Bosch F; Terol MJ; Campo E; Rozman C
    J Clin Oncol; 1994 Jul; 12(7):1343-8. PubMed ID: 8021724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
    Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
    Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients].
    García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M
    Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
    De Lena M; Ditonno P; Lorusso V; Brandi M; Timurian A; Marzullo F; Ventrella V; Pellecchia A
    J Clin Oncol; 1995 Apr; 13(4):953-60. PubMed ID: 7535844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
    Kamath SS; Marcus RB; Lynch JW; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):563-8. PubMed ID: 10348285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
    J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features and prognostic factors of primary extranodal non-Hodgkin's lymphomas in Turkey.
    Arican A; Dinçol D; Akbulut H; Onur H; Demirkazik A; Cay F; Içli F
    Am J Clin Oncol; 1999 Dec; 22(6):587-92. PubMed ID: 10597743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas.
    Esik O; Ikeda H; Mukai K; Kaneko A
    Radiother Oncol; 1996 Jan; 38(1):13-8. PubMed ID: 8850421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
    Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
    Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors in low-grade lymphoma].
    Gandarillas MA; Conde E; Mazorra F; Cuadrado MA; Baro J; Garijo J; Recio M; Richard C; Iriondo A; Zubizarreta A
    Sangre (Barc); 1998 Jun; 43(3):185-90. PubMed ID: 9741223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
    d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
    J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-Hodgkin's lymphoma in adults: a clinico-pathologic study of 169 cases].
    Ding SL; Ko WS; Hwang WS
    J Formos Med Assoc; 1990 Nov; 89(11):1017-22, 1015. PubMed ID: 1982122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
    McMaster ML; Greer JP; Wolff SN; Johnson DH; Greco FA; Stein RS; Cousar JB; Flexner JM; Hainsworth JD
    Cancer; 1991 Jul; 68(2):233-41. PubMed ID: 1712662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.
    Bosch F; López-Guillermo A; Campo E; Ribera JM; Conde E; Piris MA; Vallespí T; Woessner S; Montserrat E
    Cancer; 1998 Feb; 82(3):567-75. PubMed ID: 9452276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project.
    Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
    Med Pediatr Oncol; 1990; 18(2):89-96. PubMed ID: 2406556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution.
    Lopez-Guillermo A; Montserrat E; Bosch F; Escoda L; Terol MJ; Marin P; Reverter JC; Blade J; Cervantes F; Sierra J
    Leuk Lymphoma; 1994 Sep; 15(1-2):159-65. PubMed ID: 7858494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.